Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
Open Access
- 19 July 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (8) , 112827
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council (MR/V028448/1)
- Llywodraeth Cymru (HF-21-1886)
- Wellcome Trust (209213/Z/17/Z)
- National Institute for Health and Care Research
- UK Coronavirus Immunology Consortium
This publication has 96 references indexed in Scilit:
- Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infectionScientific Reports, 2013
- Decision making inxia2Acta Crystallographica Section D Structural Biology, 2013
- Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughFrontiers in Immunology, 2013
- TCR/pMHC Optimized Protein crystallization ScreenJournal of Immunological Methods, 2012
- Bidirectional binding of invariant chain peptides to an MHC class II moleculeProceedings of the National Academy of Sciences, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Solving structures of protein complexes by molecular replacement withPhaserActa Crystallographica Section D Structural Biology, 2006
- Protein production by auto-induction in high-density shaking culturesProtein Expression and Purification, 2005
- Structure of a Complex of the Human α/β T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401)Journal of Experimental Medicine, 2002